|
|
|
|
Ashcraft & Gerel
LLP
|
|
|
|
CELEBREX STUDY SHOWS INCREASED RISK OF HEART ATTACK AND STROKE
[Introduction: Although our offices are located in Maryland (MD), Virginia
(VA) and Washington, D.C. (DC), our drug and pharmaceutical practice is national
in scope, and our lawyers are handling many drug cases around the country.
Therefore, regardless of what state you're in, please complete our inquiry
form on this web site or email us so
that we can have an attorney from our drug litigation department contact you.]
Celebrex (celecoxib), manufactured by Pfizer Inc., is the most widely prescribed prescription arthritis pain medication in the United States. It is part of a class of pain medications known as
"Cox-2 inhibitors," of which there are three in total. Vioxx, one of the other two Cox-2 inhibitors, was withdrawn from the market on September 30, 2004 due to its link to heart attacks and strokes.
You can read about it by clicking here.
In December 2004, Bextra, the other remaining Cox-2 inhibitor that is also manufactured by Pfizer, started carrying a warning label that addresses potential heart problems associated with its use.
On December 17, 2004, Pfizer Inc. announced that a study of Celebrex showed that patients taking the drug daily had an approximately 2.5 fold increase in their risk of experiencing a major cardiovascular event. This increase in risk is even greater than the 2 fold increase shown in Vioxx studies, the same studies that prompted Merck & Co., Inc. to take Vioxx off the market!
The study that revealed the increased risk of a major fatal or non-fatal cardiovascular event
was actually a long term study for cancer sponsored by the National Cancer
Institute, but the incidental finding of a substantially higher risk of heart
attacks resulted in the study being stopped.
If you think you or a loved one may have suffered an injury or damages as a result of taking Celebrex, you owe it to yourself to speak to an experienced drug or pharmaceutical attorney about the possibility of bringing a law suit to recover for your damages and injuries. The attorney will be able to ascertain if you have a claim for which suit can be filed and that can be brought to a successful settlement, verdict, award or other recovery, and the experienced lawyer will be able to advise you on any deadlines for bringing your legal claim for damages. Please contact the law firm of Ashcraft and Gerel, LLP to discuss your case with an experienced drug or pharmaceutical lawyer in our Drug Litigation Department.
Many attorneys and law firms are now, for the first time, becoming involved in Vioxx, Celebrex, and Bextra claims, but Ashcraft & Gerel's lawyers are among the few lawyers in the country who have been actively prosecuting legal cases for Cox-2 inhibitor related injury before Vioxx was recalled from the market, and our attorneys are well situated to see Celebrex, Vioxx, and Bextra claims to successful verdicts or settlements.
The lawyers at Ashcraft and Gerel, LLP have been leaders in the prosecution of cases involving unsafe drugs. Our attorneys have successfully brought about verdicts, settlements, awards or other recoveries in claims on behalf of clients who have been injured by Fen-Phen, Rezulin, Propulsid, Phenylpropanolamine (PPA), Baycol, breast implants and AIDS tainted blood. We have a toll free number to reach an attorney to answer your questions with regard to your specific case. That number is 1-800-829-7037. Please ask to speak to Robert Samet, and he will place you in touch with one of our drug litigation lawyers. If you would prefer, please feel free to
e-mail us or complete the help inquiry form on this web
site. Please be sure to include your name, address, telephone number (if you wish to be called), email address and the exact nature of your question, so that our lawyer can provide you with the specific information you seek.
[ Return to Homepage ] [ Help ] [ Learn About Ashcraft & Gerel ] [ See Our Offices and Attorneys ] [ Email Us ] [ Links ] [Resources] [AG Friends & Associates] [ Contingent Fees in Personal Injury Litigation ] [ Workers' Compensation ] [Maryland Workers' Compensation] [District of Columbia Workers' Compensation] [Virginia Workers' Compensation] [ Product Liability Law ] [ Cerebral Palsy ] [ Medical Malpractice ] [ Automobile Accident Litigation ] [Maryland, Virginia and D.C. Injuries and Accidents] [ Birth Injury Litigation ] [ Social Security Disability ] [ Fen Phen Litigation ] [ Asbestos Litigation ] [ Toxic Tort Litigation ] [ Breast Implant Litigation ] [ Whistle Blower Litigation ] [ Construction Litigation ] [ Railroad Worker (FELA) Litigation ] [ Propulsid Litigation ] [ PPA Litigation ] [ Nursing Home Malpractice ] [ Sulzer Defective Hip Implants ] [ Defense Base Act Claims ] [ Baycol Claims ] [ Other Hip Implant Claims ] [ Thimerosal Mercury Poisoning Autism Claims ] [ Olympus Bronchoscope Claims ] [ Serzone Liver Damage Claims ] [Ephedra Claims] [Crestor Claims] [ Meridia Claims ] [ Lead Paint Claims ] [ Vioxx Claims ] [Celebrex Claims] [Bextra Claims] [Ortho Evra Claims]
